Publicacións nas que colabora con MARIA DOLORES CHIARA ROMERO (28)

2024

  1. PCDHGC3 hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas

    Journal of Pathology, Vol. 263, Núm. 4-5, pp. 418-428

2023

  1. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype

    Journal of Pathology, Vol. 259, Núm. 1, pp. 103-114

2022

  1. Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions

    Cancers, Vol. 14, Núm. 12

2020

  1. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 373-387

2019

  1. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

  2. Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations

    The Journal of clinical endocrinology and metabolism, Vol. 104, Núm. 11, pp. 5673-5692

2018

  1. Epigenetic dysregulation of TET2 in human glioblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 25922-25934

  2. SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 295-305

2017

  1. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation

    Oncotarget, Vol. 8, Núm. 8, pp. 13730-13746

  2. Control of long-distance cell-to-cell communication and autophagosome transfer in squamous cell carcinoma via tunneling nanotubes

    Oncotarget, Vol. 8, Núm. 13, pp. 20939-20960

  3. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate

    Oncotarget, Vol. 8, Núm. 4, pp. 6700-6717

2015

  1. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

    Oral Diseases, Vol. 21, Núm. 7, pp. 899-904

  2. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy

    Head and Neck, Vol. 37, Núm. 8, pp. 1150-1162

  3. PARD3 inactivation in lung squamous cell carcinomas impairs STAT3 and promotes malignant invasion

    Cancer Research, Vol. 75, Núm. 7, pp. 1287-1297

2013

  1. Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

    BMC Cancer, Vol. 13

  2. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1αmiR-210 signaling pathway

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 10

2012

  1. Identification of a signaling Axis HIF-1α/MicroRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 11

  2. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

    Clinical Cancer Research, Vol. 18, Núm. 10, pp. 2828-2837

2009

  1. Increase in gene dosage is a mechanism of HIF-lα constitutive expression in head and neck squamous cell carcinomas

    Genes Chromosomes and Cancer, Vol. 48, Núm. 5, pp. 441-454

  2. Significado pronóstico de la angiogénesis en los carcinomas epidermoides de laringe supraglótica tratados con cirugía

    Acta Otorrinolaringologica Espanola, Vol. 60, Núm. 4, pp. 272-277